TABLE-Garna Biosciences - 9-MTH group results

About this update from Carna Biosciences, Inc.

Nov 7 (Reuters)- Garna Biosciences Inc CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Sep 30, 2025 Sep 30, 2024 Dec 31, 2025 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 395 mln 487 mln 722 mln (-18.8 pct) (-31.5 pct) (+13.5 pct) Operating loss 1.55 loss 1.58 loss 2.13 Recurring loss 1.59 loss 1.58 loss 2.14 Net loss 1.60 loss 1.59 loss 2.15 EPS loss 83.76 yen loss 90.52 yen loss 112.46 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Garna Biosciences Inc. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T

View stock analysis, news, and events for Carna Biosciences, Inc.